POSITION STATEMENT FROM ISNCC, MASCC, ONS, AONS, AND EONS
Cancer is the first or second leading cause of premature death (i.e., at ages 30–69 years) in 134 of 183 countries, and it ranks third or fourth in an additional 45 countries1. An estimated 18.1 million new cancer cases and 9.6 million cancer-related deaths occurred worldwide in 20182. The incidence of cancer globally is expected to exceed 27 million new cancer cases per year by 2040 in part due to the aging of the population and greater susceptibility to aging-related diseases such as cancer3. This estimated increase in cancer incidence will occur in all countries, but the predicted increase will be proportionately greatest in low and medium countries3. Cancer is also a disease associated with significant morbidity. It is estimated that the total annual economic cost of cancer in 2010 was US$1.16 trillion per year4.
There is extensive evidence which indicates that the burden of cancer can be substantially reduced. Approximately 30%–50% of cancers can be prevented, early diagnosis and access to evidence-based treatments can significantly improve survival, and evidence-based supportive care interventions can significantly improve safety, reduce morbidity, optimize quality of life, and improve the experiences of health care for the person affected by cancer and their family. Reducing the burden of cancer is not only about limiting the numbers of those affected by cancer. It also requires actions to improve the person’s experience of cancer across the disease trajectory.
Cancer control has been a growing priority of governments globally and the World Health Organization (WHO). The 2017 World Health Assembly resolution on cancer prevention and control proposed an integrated approach to cancer control from a public policy perspective. The guiding principle of these WHO efforts is that health is a basic human right, and in order to respect that right, health services need to be provided through a universal health coverage system that leaves no one behind5.
There are over 20 million nurses and midwives worldwide, making them the largest group of health professionals who are well placed to reduce the burden of cancer. In many countries, nurses are at the frontline to reduce the burden of cancer as they provide essential primary healthcare services which includes education focused on prevention and early detection of cancer. Nurses also reduce the burden of cancer by delivering complex treatments, ensuring timely and safe minimization of complications, providing care for individuals and their families across a range of care settings, and empowering individuals and their families to assume self-management of the disease6,7. Achieving the goal of universal health coverage to reduce the burden of cancer therefore urgently requires that nursing services are not only strengthened, but that they are optimized and extended.
Nurses contribute to reducing the burden of cancer across the entire pathway.
Cancer nurses have distinct functions which are critical to the success of modern cancer care, especially in this time of unprecedented change to the nature of cancer treatment and control. These broad impacts of nursing services in cancer control is demonstrated in a growing body of evidence from studies in high resource countries. One recent scoping review of 214 studies of interventions led or delivered by cancer nurses involving 247,550 participants concluded that nursing interventions were delivered across the cancer continuum from prevention and risk reduction to survivorship. The interventions included case management, surveillance, teaching, counseling and guidance, and a variety of treatments and procedures. Most of the interventions were delivered by specialist or advanced practice nurses, highlighting the need for a robust career structure and education for nurses6.
There is substantial unrealized potential for nurses to reduce the burden of cancer across the world. In low- and middle-income countries, there is an opportunity for government and non-government organizations to improve the working conditions of nurses, such as low pay, workforce shortages, and a lack of opportunities for professional growth7,8. In many high resource countries, while specialized cancer nursing roles have developed over many decades and there is a strong evidence base to support them, there is substantial variation in access to such services and regulatory, system-level, and professional barriers which limit service delivery.
It is our position that:
Endorsed by the ONS Board of Directors February 2020.
Download this position statement.
REFERENCES
ONS stances on the healthcare issues that affect oncology nurses.
View All Position Statements